Amarin (ADR) (AMRN)
Commercializes icosapent ethyl for cardiovascular care through Vascepa and Vazkepa.
$13.75
After hours−0.08 (−0.58%)
At close$13.83(+2.60%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 42.06% | 9.32M ADS | |
|---|---|---|---|
| 86 holders · as of Jun 30, 2026 | |||
| Insiders | 0.76% | 167.7K ADS | |
| 13 holders · as of Aug 3, 2026 | |||
| Other | 57.18% | 12.67M ADS | |
| remainder | |||
22.15M ADS (1 ADS = 20 ordinary shares) as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
1 position filed across a stock split leaves its adjustment unstated and stays out of the bar.
This company has 2 share classes; every stake here is a share of the whole company.
13F, as of Jun 30, 2026
86 holders · 4.66M shares · 23 new positions · 39 increased · 12 reduced · 8 closed
| Holder | Shares | % of company | Chg q/q | Filed |
|---|---|---|---|---|
| Sarissa Capital Management LP | 1.67M | 7.55% | 0 | Aug 14, 2026 |
| Acadian Asset Management LLC | 721.0K | 3.25% | +84.2K | Aug 13, 2026 |
| Kynam Capital Management, LP | 533.0K | 2.41% | +60.6K | Aug 14, 2026 |
| Morgan Stanley | 223.6K | 1.01% | −69.6K | Aug 13, 2026 |
| Waterfront Wealth Inc. | 213.9K | 0.97% | +10.6K | Jul 30, 2026 |
| Brooklands Fund Management Ltd | 177.3K | 0.80% | +177.3K | Aug 11, 2026 |
| Eversept Partners, LP | 145.3K | 0.66% | −2.4K | Aug 14, 2026 |
| Millennium Management LLC | 115.8K | 0.52% | −184.7K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Sarissa Capital Management LPincl. Alexander J Denner | 6.09% | 13D | Aug 27, 2026 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.